Nplate — Total revenues
Amgen Nplate — Total revenues increased by 7.0% to $412M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 31.6%, from $313M to $412M. Over 4 years (FY 2021 to FY 2025), Nplate — Total revenues shows an upward trend with a 10.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing clinical adoption or expanded patient access, while a decrease may signal increased competition from biosimilars or newer therapeutic alternatives.
Detailed definition
This metric represents the total gross sales generated from the Nplate product line, a therapeutic agent used for the tr...
Peer comparison
Comparable to specialized therapeutic product revenue lines at other large-cap biotechnology firms, often benchmarked against market share in niche hematology or immunology segments.
amgn_segment_nplate_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $245M | $273M | $282M | $266M | $284M | $288M | $459M | $362M | $310M | $419M | $386M | $317M | $346M | $456M | $337M | $313M | $369M | $457M | $385M | $412M |
| QoQ Change | — | +11.4% | +3.3% | -5.7% | +6.8% | +1.4% | +59.4% | -21.1% | -14.4% | +35.2% | -7.9% | -17.9% | +9.1% | +31.8% | -26.1% | -7.1% | +17.9% | +23.8% | -15.8% | +7.0% |
| YoY Change | — | — | — | — | +15.9% | +5.5% | +62.8% | +36.1% | +9.2% | +45.5% | -15.9% | -12.4% | +11.6% | +8.8% | -12.7% | -1.3% | +6.6% | +0.2% | +14.2% | +31.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Amgen's nplate — total revenues?
- Amgen (AMGN) reported nplate — total revenues of $412M in Q1 2026.
- How has Amgen's nplate — total revenues changed year-over-year?
- Amgen's nplate — total revenues increased by 31.6% year-over-year, from $313M to $412M.
- What is the long-term trend for Amgen's nplate — total revenues?
- Over 4 years (2021 to 2025), Amgen's nplate — total revenues has grown at a 10.4% compound annual growth rate (CAGR), from $1.03B to $1.52B.
- What does nplate — total revenues mean?
- The total revenue generated from sales of the Nplate therapeutic product.